Tag - breast-cancer

 
 

BREAST CANCER

Daiichi Sankyo's headquarters in Tokyo
BUSINESS
Jan 18, 2025
AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.
Gabriela Dabrowski (right) and Erin Routliffe celebrate after winning the doubles final at the WTA Finals in Riyadh on Nov. 9, 2024.
TENNIS
Jan 2, 2025
Gabriela Dabrowski reveals run to Olympic bronze came amid cancer treatment
Dabrowski said her "surreal" second half of the 2024 season included two surgeries and radiotherapy.
Dani Alderman, 31, who was diagnosed in May 2023 with triple negative breast cancer, at her apartment in Manhattan on Sunday
WORLD / Science & Health
Oct 2, 2024
Breast cancer cases continue to rise among younger women, study finds
One in 50 U.S. women will develop invasive breast cancer by age 50, according to the American Cancer Society report.
JAPAN / Science & Health
Nov 16, 2023
Heart failure drugs may help prevent breast cancer relapse: Japanese study
The study, conducted by a team of Japanese researchers, could lead to the future development of a therapy for patients with triple-negative breast cancer.
Single-use bathing wear that comes in the form of a blouse or a dress
JAPAN / Society / Regional Voices: Kyushu
Nov 6, 2023
Breast cancer survivors face tough time at public baths
It is customary in Japan not to take clothing or towels into the water at public baths, and some facilities make it a rule for hygienic reasons.
A radiographer prepares a patient to undergo a mammogram to look for early signs of breast cancer in the radiology unit at a hospital in Nairobi.
WORLD / Science & Health
Aug 2, 2023
AI could halve time reading breast cancer scans, study suggests
The interim results of the trial were hailed as promising, but the authors cautioned that more research is needed.
Japan Times
COMMENTARY / World
Jun 23, 2023
Eradicate breast cancer? The hunt for a vaccine looks promising
Women in the future may soon be able to get a series of shots that teach their immune systems how to quash breast cancer before it becomes a problem.
Japan Times
WORLD / Science & Health
Jun 3, 2023
Breast cancer drug shown to reduce recurrence risk
Even when the disease is caught early, breast cancer recurrence is relatively common — and for survivors, the prospect can be daunting.
Japan Times
WORLD / Science & Health
May 10, 2023
Mammograms should start at 40, U.S. task force says
Breast cancer is the second-most common cancer and the second-most common cause of cancer death for women in the United States.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
BUSINESS / Tech
Jan 2, 2020
Study finds Google system could improve breast cancer detection
A Google artificial intelligence system has proved as good as expert radiologists at predicting which women would develop breast cancer based on screening mammograms and also showed promise at reducing errors, researchers in the United States and Britain reported.
Japan Times
COMMUNITY / Voices / FOREIGN AGENDA
Oct 23, 2019
Finding moments of strength with every step of my cancer journey
It's the diagnosis that nobody wants to hear. But along with the moments of shock, stress and sadness that Julia Marino has experienced on her cancer journey, she has also found strength.
WORLD / Science & Health
Jun 3, 2018
Study finds many women with early-stage breast cancer can skip chemotherapy
Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S. researchers said Sunday.
WORLD / Science & Health
Dec 9, 2017
Pfizer's breast cancer drug found to be superior to chemotherapy in Phase III study
Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer drug went about three months longer before their disease worsened than those who received chemotherapy in a late-stage study, according to data released Friday.
Japan Times
LIFE / Lifestyle
Sep 30, 2017
Winning the battle against breast cancer
Oct. 1 marks the start of the annual Pink Ribbon campaign to raise awareness about breast cancer.

Longform

Atsuyoshi Koike, the president and CEO of Rapidus, says there is a “sense of urgency” when it comes to Japan’s efforts in manufacturing semiconductors. “We have to make sure we are successful,” he says.
Atsuyoshi Koike’s big game: Fourth down and 2 nanometers to go